What's behind Hims & Hers Health's latest stock pullback?

Traders Union
All News
Stocks
Hims & hers slides 8.7% today

Highlights

Hims & Hers Health is under persistent selling pressure, trading below key short-, medium-, and long-term moving averages.
Momentum signals are mixed, with short-term buy signals offset by oversold oscillators and a weak overall tone.
Expect a sideways consolidation near $29.89, with a five-day trading range of $27.49 to $33.77 barring a breakout.

Anton Kharitonov, expert at Traders Union, sees persistent technical weakness in Hims & Hers Health Inc, with the stock below all key moving averages. The absence of any news catalyst leaves sentiment fragile and momentum indicators add to the negative tone. The long-term trend remains down, while a neutral ADX and oversold stochastic point to merely temporary buyer interest. Volatility is elevated and structural risks outweigh upside scenarios for now. He cautions, "The technical setup suggests more downside could develop unless a strong reversal emerges above $30.24."

Viktoras Karapetjanc, expert at Traders Union, views the recent sell-off as a potential opportunity. He notes that despite the sharp drop, oversold indicators and early buyer activity indicate potential for swift reversals. The bullish structure remains intact if the price retakes $30.24, and the volatility creates setups for agile traders. Karapetjanc emphasizes forward-looking potential, stating, "I'm confident that breaking above $30.24 will unlock fresh momentum and set up for a strong recovery toward $33.77."

Parshwa Turakhiya, analyst, highlights that HIMS faces mixed short-term sentiment amid technical weakness and lack of news. Support at $29.4 attracts watchful buyers, but indicators like the RSI and stochastic flag oversold risks. He sees range-bound action as most likely in the coming days, favoring tactical trades over trends. Turakhiya adds, "Traders should watch for quick swings between $29.4 and $30.24 as short-term sentiment drives sharp, tradeable moves."

Mixed momentum supports weakness as oversold signals mount under resistance

Hims & Hers Health is trading below the 20-day, 50-day, and 200-day moving averages, with the current price at $29.89 versus the MA-20 at $34.63, MA-50 at $30.24, and MA-200 at $31.19. This configuration reflects downward pressure across short-, medium-, and longer-term trends, with a near-term support level at today's low of $29.4 and resistance at the MA-50, $30.24. Momentum indicators are mixed: the MACD signals strong short-term buy momentum, however, the RSI is below 50 at 48.98 and indicates a sell, confirmed by the CCI at -68.79 and the Stochastic RSI at 15.02, signaling oversold conditions. The ADX remains neutral at 19.55, and Bull/Bear Power is positive at 2.13, pointing to early session buyer activity, but persistent selling pressure defines the session as volatility reached 16.73%.

Earlier, analysts noted that Hims & Hers Health was under sustained technical pressure as bearish sentiment dominated trading activity. With the latest decline reinforcing downside momentum despite mixed signals from momentum indicators, traders should monitor any decisive break below $29.4, as this could elevate the risk of a move toward the $27.49 support zone.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.